Patents by Inventor Winthrop Jackman

Winthrop Jackman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NON-SPLICING VARIANTS OF GP350/220
    Publication number: 20130064844
    Abstract: Compositions comprising gp350 variant DNA and amino acid sequences are provided, as are vectors and host cells containing such sequences. Also provided is a process for producing homogeneous gp350 protein recombinantly and in the absence of production of gp220 protein, pharmaceutical compositions containing such protein and prophylactic treatments making use of such proteins.
    Type: Application
    Filed: August 22, 2012
    Publication date: March 14, 2013
    Applicant: MedImmune, LLC
    Inventors: Richard Spaete, Winthrop Jackman
  • NON-SPLICING VARIANTS OF gp350/220
    Publication number: 20120058136
    Abstract: Compositions comprising gp350 variant DNA and amino acid sequences are provided, as are vectors and host cells containing such sequences. Also provided is a process for producing homogeneous gp350 protein recombinantly and in the absence of production of gp220 protein, pharmaceutical compositions containing such protein and prophylactic treatments making use of such proteins.
    Type: Application
    Filed: May 26, 2011
    Publication date: March 8, 2012
    Applicant: MedImmune, LLC
    Inventors: Richard SPAETE, Winthrop Jackman
  • NON-SPLICING VARIANTS OF GP350/220
    Publication number: 20110059486
    Abstract: Compositions comprising gp350 variant DNA and amino acid sequences are provided, as are vectors and host cells containing such sequences. Also provided is a process for producing homogeneous gp350 protein recombinantly and in the absence of production of gp220 protein, pharmaceutical compositions containing such protein and prophylactic treatments making use of such proteins.
    Type: Application
    Filed: March 3, 2010
    Publication date: March 10, 2011
    Applicant: MEDIMMUNE, LLC
    Inventors: Richard SPAETE, Winthrop JACKMAN
  • Non-Splicing Variants of gp350/220
    Publication number: 20090263412
    Abstract: Compositions comprising gp350 variant DNA and amino acid sequences are provided, as are vectors and host cells containing such sequences. Also provided is a process for producing homogeneous gp350 protein recombinantly and in the absence of production of gp220 protein, pharmaceutical compositions containing such protein and prophylactic treatments making use of such proteins.
    Type: Application
    Filed: February 11, 2008
    Publication date: October 22, 2009
    Inventors: Richard Spaete, Winthrop Jackman
  • Non-splicing variants of gp350/220
    Publication number: 20070202122
    Abstract: Compositions comprising gp350 variant DNA and amino acid sequences are provided, as are vectors and host cells containing such sequences. Also provided is a process for producing homogeneous gp350 protein recombinantly and in the absence of production of gp220 protein, pharmaceutical compositions containing such protein and prophylactic treatments making use of such proteins.
    Type: Application
    Filed: September 21, 2006
    Publication date: August 30, 2007
    Applicant: MEDIMMUNE, INC.
    Inventors: Richard Spaete, Winthrop Jackman
  • Non-splicing variants of gp350/220
    Publication number: 20040137008
    Abstract: Compositions comprising gp350 variant DNA and amino acid sequences are provided, as are vectors and host cells containing such sequences. Also provided is a process for producing homogeneous gp350 protein recombinantly and in the absence of production of gp220 protein, pharmaceutical compositions containing such protein and prophylactic treatments making use of such proteins.
    Type: Application
    Filed: November 25, 2003
    Publication date: July 15, 2004
    Inventors: Richard Spaete, Winthrop Jackman
  • Non-splicing variants of gp350/220
    Patent number: 6692749
    Abstract: Compositions comprising gp350 variant DNA and amino acid sequences are provided, as are vectors and host cells containing such sequences. Also provided is a process for producing homogeneous gp350 protein recombinantly and in the absence of production of gp220 protein, pharmaceutical compositions containing such protein and prophylactic treatments making use of such proteins.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: February 17, 2004
    Assignee: MedImmune Vaccines, Inc.
    Inventors: Richard Spaete, Winthrop Jackman